Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

8,036 public trials 1,520 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Recruiting

a PROspective Case Control Study to Develop and Validate a Blood Test FOr mUlti-caNcers Early Detection（PROFOUND）

NCT06217900

Conditions
Cancer, Neoplasms
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University Cancer Hospital and Institute Beijing, Beijing Municipality, China
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China
  • The First Hospital of Jilin University Changchun, China
View Trial Details
Recruiting

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

NCT07566156

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Samsun Clinic - Ridley-Tree Cancer Center Santa Barbara, California, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
  • Illinois Cancer Specialists Niles, Illinois, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View all 14 locations
View Trial Details
Recruiting

A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

NCT07030712

Conditions
Metastatic Neoplasm, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Northwestern University ( Site 0101) Chicago, Illinois, United States
  • Rambam Health Care Campus ( Site 0201) Haifa, Israel
  • Sheba Medical Center ( Site 0200) Ramat Gan, Israel
  • Radboudumc ( Site 0301) Nijmegen, Gelderland, Netherlands
View Trial Details
Recruiting

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

NCT05920356

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Sansum Clinic Santa Barbara, California, United States
  • Medical Oncology Hematology Consultants Helen F Graham Cancer Center Newark, Delaware, United States
  • University of Illinois Chicago Chicago, Illinois, United States
  • Illinois Cancer Specialists Niles, Illinois, United States
View all 418 locations
View Trial Details
Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

NCT07365241

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063 Birmingham, Alabama, United States
  • Usa Mitchell Cancer Institute /ID# 280198 Mobile, Alabama, United States
  • City Of Hope - Phoenix /ID# 281323 Goodyear, Arizona, United States
  • City of Hope National Medical Center /ID# 281322 Duarte, California, United States
View all 62 locations
View Trial Details
Recruiting

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

NCT07630974

Conditions
Malignant Neoplasm, Neoplasms
Locations
  • University of Iowa Hospitals ( Site 4017) Iowa City, Iowa, United States
  • Dana Farber Cancer Center ( Site 4013) Boston, Massachusetts, United States
  • Rutgers Cancer Institute of New Jersey ( Site 4008) New Brunswick, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center ( Site 4010) New York, United States
View all 25 locations
View Trial Details
Recruiting

Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma

NCT07000253

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +14 more
Locations
  • Amsterdam University Medical Center Amsterdam, Netherlands
  • UMC Utrecht Utrecht, Netherlands
  • University of Oslo Oslo, Norway
  • University of North Norway Tromsø, Norway
View Trial Details
Recruiting

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

NCT07504458

Conditions
Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia, Acute Promyelocytic Leukemia (APL), +12 more
Locations
  • Quetzal Site 1 Duarte, California, United States
  • Quetzal Site 7 Los Angeles, California, United States
  • Quetzal Site 5 Stanford, California, United States
  • Quetzal Site 4 Buffalo, New York, United States
View all 24 locations
View Trial Details

Related conditions